Middle East & Africa Ophthalmic Clinical Trials Market Size & Outlook
Related Markets
MEA ophthalmic clinical trials market highlights
- The MEA ophthalmic clinical trials market generated a revenue of USD 57.5 million in 2023.
- The market is expected to grow at a CAGR of 4.1% from 2024 to 2030.
- In terms of segment, drugs was the largest revenue generating product in 2023.
- Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 57.5 million |
| Market revenue in 2030 | USD 76.4 million |
| Growth rate | 4.1% (CAGR from 2023 to 2030) |
| Largest segment | Drugs |
| Fastest growing segment | Drugs |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drugs, Devices |
| Key market players worldwide | Charles River Laboratories International Inc, Icon PLC, IQVIA Holdings Inc, Labcorp Holdings Inc, Medpace Holdings Inc, Vial, ProTrials Research, Syneos Health, Worldwide Clinical Trials, ProRelix Research |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.5% of the global ophthalmic clinical trials market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 516.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Clinical Trials Market Scope
Ophthalmic Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ProRelix Research | View profile | 11-50 | Pune, Maharashtra, India, Asia | https://prorelixresearch.com/ |
| Worldwide Clinical Trials | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.worldwide.com |
| ProTrials Research | View profile | 101-250 | San Jose, California, United States, North America | http://protrials.com |
| Vial | View profile | 101-250 | San Francisco, California, United States, North America | https://vial.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
Middle East & Africa ophthalmic clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic clinical trials market will help companies and investors design strategic landscapes.
Drugs was the largest segment with a revenue share of 75.65% in 2023. Horizon Databook has segmented the Middle East & Africa ophthalmic clinical trials market based on drugs, devices covering the revenue growth of each sub-segment from 2018 to 2030.
- Middle East & Africa Ophthalmic Clinical Trials Product Outlook (Revenue, USD Million, 2018-2030)
- Drugs
- Prescription Drugs
- OTC Drugs
- Devices
- Vision care Devices
- Surgical & Diagnostics Devices
- Drugs
- Middle East & Africa Ophthalmic Clinical Trials Indications Outlook (Revenue, USD Million, 2018-2030)
- Retinopathy
- Macular Degeneration
- Dry Eye Disease
- Uveitis
- Cataract
- Macular Edema
- Blepharitis
- Optic Neuropathy
- Glaucoma
- Others
- Middle East & Africa Ophthalmic Clinical Trials Phase Outlook (Revenue, USD Million, 2018-2030)
- Clinical Phase
- Discovery Phase
- Preclinical Phase
- Middle East & Africa Ophthalmic Clinical Trials Sponsor Type Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical/Biopharmaceutical Companies
- Others
- Medical Device Companies
Reasons to subscribe to Middle East & Africa ophthalmic clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa ophthalmic clinical trials market databook
-
Our clientele includes a mix of ophthalmic clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa ophthalmic clinical trials market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa ophthalmic clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA ophthalmic clinical trials market outlook size, by country, 2018-2030 (US$M)
Middle East & Africa Ophthalmic Clinical Trials Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
